Pharmafile Logo
Pharmafocus logo
Advanced Search

Astellas breaks ground on $95m antibody facility

January 20, 2011
Manufacturing and Production Agensys, Astellas, antibodies, antibody

Astellas has broken ground on a $95 million R&D and manufacturing facility in Santa Monica, USA, that will also serve …

News

Caution raised on statins in healthy people

January 20, 2011
Sales and Marketing Cochrane, Crestor, Lipitor, statin, statin prescribing

Researchers have warned of a lack of evidence to support prescribing statins in patients at low risk of developing heart …

News
Image of Dr Thomas Lönngren

Ex head of European Medicines Agency (EMA) teams up with NDA

January 20, 2011

With new drug development costs soaring the NDA Group launches a new regulatory and market access business that aims to …

Appointment

Key drug launches for 2011

January 20, 2011
Sales and Marketing Benlysta, Cladribine, Movectro, Pradaxa, Xarelto, axitinib, boceprevir, crizotinib, telaprevir

This year is expected to see new treatments for hepatitis C, multiple sclerosis and lupus among those that could reach …

Feature

Cancer Drugs Fund must not be forerunner to value-based pricing – EMIG

January 19, 2011
Sales and Marketing Cancer Drugs Fund, EMIG, Ethical Medicines Industry Group, NHS, value-based pricing

The association representing small to medium UK pharma companies says the forthcoming Cancer Drugs Fund is welcome – but must …

News
Roche building

Trial success for Roche’s personalised skin cancer drug

January 19, 2011
Research and Development BRAF V600, Cancer, RG7204, Roche, personalised medicine, skin cancer

A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …

News

EMA’s Thomas Lönngren joins market access firm

January 19, 2011
Research and Development, Sales and Marketing NDA Group, Thomas Lönngren, appointment, recruitment, research and development, sales and marketing

The former head of the EMA Thomas Lönngren has taken up a post at new European regulatory and market access …

News

Sanofi ‘considering’ raising Genzyme offer

January 19, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions

Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …

News

Success in pre-clinical microRNA treatment of prostate cancer

January 19, 2011
Research and Development MD Anderson Cancer Center, MicroRNA, Mirna Therapeutics, RNA interfering, miRNA, prostate cancer, rnai

A new MicroRNA treatment for prostate cancer has been highly effective against the disease in pre-clinical studies. MicroRNAs, or miRNAs, …

News

Syntaxin appoints Russell Greig chairman

January 19, 2011
Research and Development Russell Greig, appointment, research and development, syntaxin

Oxford, UK-based biotechnology company Syntaxin has appointed Dr Russell Greig as its new chairman.Russell has over 30 years experience in …

Appointment

Online physician communities in UK and France join forces

January 19, 2011
Medical Communications, Sales and Marketing Egora, Global Media Sante, doctors communities, doctors.net, online communities

Two online communities for doctors have launched a strategic alliance to help them expand their reach. UK-based Doctors.net.uk is teaming …

News

Double Helix appoints Hollie Durrance and Gavin Harper

January 18, 2011
Medical Communications Double Helix, Gavin Harper, Hollie Durrance, appointment, medical communications

Global market research consultancy Double Helix has appointed Hollie Durrance as research manager and Gavin Harper as trainee research executive …

Appointment

Chiltern wins multiple Pharma Awards at the prestigious annual Pharmatimes Awards Ceremony

January 18, 2011
Research and Development

 

News
Press release

MPs hit out at NHS reforms

January 18, 2011
GP consortia, Health Select Committee, NHS, NHS reforms, PCTs

MPs have come out against the NHS White Paper, saying it has caused wide spread uncertainty at a time when …

News

European Commission launches new generic deal review

January 18, 2011
Sales and Marketing European Commission, anti-trust investigation, competition, generics

The European Commission has asked a number of firms to submit copies of their patent settlements in 2010 to see …

News

GSK takes £2.2bn hit from Avandia claims

January 18, 2011
Sales and Marketing Avandia, GSK, GlaxoSmithKline, rosiglitazone

GlaxoSmithKline’s Avandia woes are continuing, with the company admitting it expects to take a mammoth legal charge over the troubled …

News

Merck Serono and Domain to co-develop Parkinson’s drugs

January 18, 2011
Research and Development Domain Therapeutics, Merck KGaA, Merck Serono, PAM, Parkinson's disease, Parkinson’s disease, Positive Allosteric Modulator, mGluR4, metabotropic glutamate receptor 4

Merck Serono is to work with French biotech company Domain Therapeutics to develop a new treatment for Parkinson’s disease and …

News

Merck suffers late-stage blow to vorapaxar

January 18, 2011
Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar

An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …

News

BMS and Sanofi recall 64 million Avalide tablets

January 18, 2011
Manufacturing and Production Avalide, Avapro, Bristol-Myers Squibb, GMP, Good Manufacturing Practice, Sanofi-Aventis, hypertension, irbesartan

Bristol-Myers Squibb and Sanofi-Aventis have started another massive recall of their antihypertensive product Avalide because a manufacturing defect could affect …

News

Merck taps Parexel to help it meet biosimilar ambitions

January 18, 2011
Research and Development Merck & Co, Parexel, biosimilars

Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026